When the German pharmaceutical company Boehringer Ingelheim developed the anti-depressant drug Flibanserin, the company had no idea that after a few Flibanserin clinical trials they would be seeking FDA approval to relieve the symptoms of female sexual dysfunction in pre-menopausal women of all ages.
Several years ago Pfizer went through a similar situation with their drug Sildenafil. Sildenafil was developed as a hypertension medication, but the early trials showed that Sildenafil increased the blood flow to the penis and that alleviated the main cause of male erectile dysfunction.
Sildenafil, better known as Viagra, is now the number one selling drug in the world with sales that exceed over $1 billion dollars a year.
If Boehringer is able to get FDA approval based on the Flibanserin clinical tests conducted over the last several years it could exceed Viagra sales, but there is a great deal of secrecy surrounding the actual product line; several brand names have been considered.
Girosa or Ectris are the main contenders, but it looks the Girosa brand name will be introduced first.
The latest Flibanserin clinical trials show that the drug increases sexual desires as well as sexual satisfying events in women with a low or non-existent libido.
The results of the Flibanserin clinical trials were presented to the European Society for Sexual Medicine in Lyon France; the average number of satisfying sexual experiences in those trials increased from three to five a month.
The women who participated in the Flibanserin clinical trials took 100mg of Flibanserin once a day for forty-eight weeks.
Boehringer claims that the Flibanserin clinical trials prove that the drug increases dopamine and noradrenalin and decreases serotonin levels in the brain.
Boehringer has conducted four Flibanserin clinical trials on over five thousand women in three hundred and fifty locations around the world, but the truth is no one is really sure how Flibanserin increases sexual desire.
The 2009 Flibanserin clinical trials assessed the safety of the drug on pre and post menopausal women, but those results are based on self-evaluation, so the results are hard to accurately measure.
The Results of Flibanserin Clinical Trials Show a Few Side Effects
Flibanserin clinical trials indicate that Flibanserin use may produce side effects like headaches, fatigue, dizziness, nausea, sinusitis, and diarrhea. Some women expect side effects from prescription medications, but they are unnecessary.